2025
article
OpenAlex
Vidya Veldore, Vanita Noronha, Vijay Patil, Nishtha Tanwar et autres
e18025 Background: HNSCC imparts rising incidence and mortality rate worldwide, due to lack of information regarding spatial and temporal heterogeneity of the tumors. Nearly 50 to 60% of advanced node positive HNSCC are known to develop platinum resistance during the course of …
in
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Satya Prakash Khuntia, Nilesh Mukherjee, J Vyomesh, Jinumary John et autres
e15094 Background: Comprehensive genomic profiling (CGP) is essential for identifying actionable and prognostic biomarkers in oncology practice. This study investigates oncogenic alterations, key driver mutations, and co-mutation patterns in Indian cancer patients. By targeting hallmark pathways driving disease progression, it highlights the …
in
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
N Srivatsa, Hari PS, P. Patel Rahul, Lista Paul et autres
BACKGROUND: Bladder cancer represents a heterogeneous disease with distinct clinical challenges. Non-muscle invasive bladder cancer (NMIBC) typically presents as indolent and slow-growing, yet a critical clinical challenge remains: identifying which patients will progress to muscle-invasive disease requiring radical interventions. Early detection of …
in, jp
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
N Srivatsa, Parameswaran Hari, P. Patel Rahul, Lista Paul et autres
in
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Satya Prakash Khuntia, Nilesh Mukherjee, Vyomesh Javle, Nishtha Tanwar et autres
PURPOSE Gene fusions are critical oncogenic mutations that drive cancer development and serve as diagnostic and prognostic biomarkers. Despite the increasing cancer burden in India, large-scale analyses of molecular landscapes, particularly gene fusions, have been relatively scarce. MATERIALS AND METHODS This retrospective …
in
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Elveera Saldanha, Raunak Kumar, Sreekanth Reddy Peddagangannagari, Priyanka Pange et autres
*Corresponding author : (e-mail: pratikchandrani@gmail.com).
in
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Kumar Prabhash, Elveera Saldanha, Vijay Patil, Munita Bal et autres
PURPOSE Medullary thyroid cancer (MTC) is a rare cancer originating from parafollicular C cells of the thyroid gland. Therapeutically relevant alterations in MTC are predominantly reported in RET oncogene, and lower-frequency alterations are reported in KRAS and BRAF . Nevertheless, there is …
in
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Nusrath Fathima, Krithika Verma, Paridhy Vanniya Subramanyam, Nilesh Mukherjee et autres
ABSTRACT Background: An increase in colorectal cancer incidence has been reported in India, often presenting in advanced stages and resulting in poor survival. However, the genomic and therapeutic landscape is not well understood. Objective: The primary objective of the study was to …
in, ph, np
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Sun P, Srihari Sharma, Rahul Pappala, D. Devi et autres
in
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Nasreen Parween, Trisha Dutta Gupta, Paridhy Vanniya Subramanyam, Nishtha Tanwar et autres
Background: Homologous recombinant repair (HRR) deficit and the associated sensitivity to poly (ADP-ribose) polymerase inhibitors (PARPi) has been well studied in breast, ovarian, prostate, and pancreatic cancers, but very little is known about it in other cancer types. Objectives: We sought to …
in, np
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Nishtha Tanwar, Richa Malhotra, Aiswarya Padmaja Satheesh, Satya Prakash Khuntia et autres
PURPOSE: The purpose of this study was to understand the impact of population diversity and geographic variation on tumor mutation burden (TMB) scores across cancers and its implication on stratification of patients for immune checkpoint inhibitor (ICI) therapy. MATERIALS AND METHODS: This …
in
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Richa Malhotra, Vyomesh Javle, Nishtha Tanwar, Pooja Gowda et autres
Introduction: The concept of personalized medicine in cancer has emerged rapidly with the advancement of genome sequencing and the identification of clinically relevant variants that contribute to disease prognosis and facilitates targeted therapy options. In this study, we propose to validate a …
in
(code pays fourni par la source)